Entries by

Polyganics signs up multiple distributors in Europe to accelerate roll-out of Peripheral Nerve Repair portfolio

8th June 2017 in /by

Groningen, The Netherlands, 8 June 2017 – Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it has signed agreements with leading medical technology distributors in Europe, to meet the growing distribution demands for Polyganics’ Peripheral Nerve Repair (PNR) […]

Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study

20th April 2017 in /by

Groningen, The Netherlands, 20 April 2017 – Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it has enrolled the first patient in its international PROTECT NEURO study to treat and prevent symptomatic neuroma. The first patient was treated […]

Polyganics’ “STOP NEUROMA” Study Interim Data Shows Reduction in Pain

16th February 2017 in /by

NEUROCAP® 3-month interim data show an average pain reduction of 84% Final patient recruited in “STOP NEUROMA” clinical study, full data due to be reported by Q3 2018. Groningen, The Netherlands 16 February 2017 – Polyganics, a privately held medical technology company, announced today that interim results show a sharp improvement in pain reduction observed across […]

Polyganics Announces CE Mark for NEUROCAP®, the Nerve Capping Device for Treatment and Prevention of Symptomatic Neuroma

21st June 2016 in /by

Groningen, The Netherlands, 21 June 2016 – Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it has received the CE mark for NEUROCAP®, its nerve capping device. Polyganics intends to launch NEUROCAP® in several European countries later this year. […]

Polyganics Announces Enrollment of First Patients in Multicenter Study for NEUROCAP® Nerve Capping Device

10th May 2016 in /by

Groningen, The Netherlands, 9 May 2016,  Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that the first four patients have been enrolled in the “STOP NEUROMA” study. The STOP NEUROMA study (Surgical Treatment Of symPtomatic Neuroma) will examine the […]

Polyganics appoints Dr Jan Öhrström to Supervisory Board

15th March 2016 in /by

Groningen, The Netherlands, 15 March 2016 – Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve repair, neurosurgery, general surgery, as well as ear, nose & throat surgery, today announced it has appointed Dr Jan K. Öhrström to its Supervisory Board. The appointment is effective […]

Polyganics Receives Chinese Food and Drug Administration (CFDA) Approval for NEUROLAC®

26th February 2016 in /by

Beijing, China, 26 February 2016 – Polyganics today announced it has received Chinese FDA (CFDA) clearance for NEUROLAC®, a unique synthetic and resorbable nerve conduit designed to support regeneration of peripheral nerve discontinuities up to 20 mm in patients who have sustained a complete division of a nerve. Rudy Mareel, CEO a.i.:  “NEUROLAC® offers a […]

Polyganics Receives FDA 510(k) Clearance for Nerve Capping Device NEUROCAP®

26th January 2016 in /by

Groningen, The Netherlands, 26 January 2016 – Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve repair, neurosurgery, general surgery, as well as ear, nose & throat surgery, today announced it has received FDA 510(k) clearance for NEUROCAP, an innovative device designed to reduce painful […]

Polyganics and MicroAire sign exclusive distribution agreement for peripheral nerve repair portfolio in the US, Canada and Puerto Rico

21st January 2016 in /by

Groningen, The Netherlands, 21 January 2016 – Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve repair, neurosurgery, general surgery, as well as ear, nose & throat surgery, today announced it has signed an exclusive distribution agreement with its strategic partner MicroAire Surgical Instruments LLC […]